Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

AdobeStock 824760386

Scientists develop novel one-step method for multiple genome edits

, 20 August 2024/in E-News /by panglobal

Researchers at Gladstone Institutes have created a groundbreaking technique that allows for simultaneous, precise edits at multiple locations within a cell’s genome, potentially revolutionising genetic research and therapeutic development.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/AdobeStock_824760386.jpeg 1080 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 12:27:192024-08-20 12:27:19Scientists develop novel one-step method for multiple genome edits
Alexandrov Ludmil

New AI tool promises rapid cancer biomarker detection from biopsy slides

, 20 August 2024/in E-News /by panglobal

Researchers at the University of California San Diego have developed an artificial intelligence system that could revolutionise precision oncology by identifying key genomic alterations directly from tumour biopsy images, potentially saving crucial time and resources in cancer treatment.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/Alexandrov_Ludmil.jpg 1058 1410 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 12:17:532024-08-20 12:18:45New AI tool promises rapid cancer biomarker detection from biopsy slides
3D VTB GE 2

New 3D mapping technology offers unprecedented insight into tissue architecture at subcellular level

, 20 August 2024/in E-News /by panglobal

Researchers at the Max Delbrück Center have developed an open-source platform called Open-ST that creates high-resolution 3D maps of gene expression in tissue samples, potentially revolutionising our understanding of disease processes and enhancing clinical pathology.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/3D_VTB_GE_2.jpg 700 599 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 12:10:152024-08-20 12:10:15New 3D mapping technology offers unprecedented insight into tissue architecture at subcellular level
human gastruloid

New Code of Practice for stem cell-based embryo models addresses ethical concerns

, 20 August 2024/in E-News, Pathology & Histology /by panglobal

Scientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/human-gastruloid.jpg 675 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 12:05:072024-08-22 08:43:16New Code of Practice for stem cell-based embryo models addresses ethical concerns
nanobubbles

Scientists make breakthrough in medical imaging and drug delivery with ultrasmall nanobubbles

, 20 August 2024/in E-News, Therapeutic Drug Monitoring /by panglobal

Rice University bioengineers have developed the smallest free-floating gas-filled structures for medical imaging, potentially revolutionising ultrasound technology and targeted drug delivery.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/nanobubbles.jpg 1128 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 11:52:452024-08-22 08:43:38Scientists make breakthrough in medical imaging and drug delivery with ultrasmall nanobubbles
Scherm­afbeelding 2024 08 20 om 13.45.37

Researchers develop efficient method to generate endothelial cells from stem cells

, 20 August 2024/in E-News, Pathology & Histology /by panglobal

A team at the University of Bonn has established a highly efficient and cost-effective technique to produce functional endothelial cells from human induced pluripotent stem cells, potentially advancing cardiovascular disease research and organoid development. Scientists at the University Hospital Bonn (UKB) and the University of Bonn have made significant strides in the field of cardiovascular […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/Scherm­afbeelding-2024-08-20-om-13.45.37.jpg 820 1104 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 11:47:352024-08-22 08:43:51Researchers develop efficient method to generate endothelial cells from stem cells
Scherm­afbeelding 2024 08 20 om 12.07.55

ELRIG UK and The Protein Society collaborate to advance protein sciences in drug discovery

, 20 August 2024/in E-News, Therapeutic Drug Monitoring /by panglobal

The European Laboratory Research & Innovation Group (ELRIG) UK and The Protein Society (TPS) have announced a partnership aimed at advancing protein sciences in drug discovery. This collaboration will culminate in a joint conference, ‘Protein Sciences in Drug Discovery’, scheduled for 18-19 November 2024 in Cambridge, UK.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/Scherm­afbeelding-2024-08-20-om-12.07.55.jpg 772 1536 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 10:10:292024-08-20 10:10:29ELRIG UK and The Protein Society collaborate to advance protein sciences in drug discovery
AdobeStock 892534593

Sapio Sciences unveils partner programme to boost research and diagnostic capabilities

, 20 August 2024/in E-News /by panglobal

In a move set to advance the lab informatics landscape, Sapio Sciences has launched its Partner Programme. This initiative aims to foster a robust ecosystem of technology vendors, service providers, and resellers, equipping them with essential resources to deliver cutting-edge solutions for scientists.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/AdobeStock_892534593.jpeg 1080 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 09:34:402024-08-20 09:56:31Sapio Sciences unveils partner programme to boost research and diagnostic capabilities
Surfix Diagnostics 1

New collaboration aims to enhance colorectal cancer screening accuracy

, 20 August 2024/in E-News, Tumour Markers /by panglobal

A new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/Surfix-Diagnostics-1.jpg 1281 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 09:21:452024-08-20 09:21:45New collaboration aims to enhance colorectal cancer screening accuracy
SciRhom

SciRhom raises €63 million to advance iRhom2-targeting therapies for autoimmune diseases

, 20 August 2024/in Autoimmunity & Allergy, E-News /by panglobal

Munich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/SciRhom.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 08:47:442024-08-20 13:45:21SciRhom raises €63 million to advance iRhom2-targeting therapies for autoimmune diseases
Page 20 of 228«‹1819202122›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription